Last year, when the number of COVID-19 cases and deaths continued to climb, we put our hopes on the development of vaccines. When the good news came about the efficacy of the Pfizer-BioNTech and Moderna vaccines in November—practically ...
Feb 1, 2021
0
2
Getting a COVID-19 vaccine to the right people could change the course of the pandemic in the United States. But who are the right people?
Dec 4, 2020
0
2
Disputes over the Oxford/AstraZeneca vaccine have dominated the week, just as they have at various points over the past few months.
Mar 26, 2021
0
0
European Commission chief Ursula von der Leyen insisted Wednesday that problems dogging vaccine supplies to the EU can be resolved, after AstraZeneca said it could deliver only half of its expected amount in the second quarter.
Feb 24, 2021
0
1
The European Union's problems with getting deliveries of coronavirus vaccines have underscored the need for the bloc to redouble its efforts to produce its own doses, German Chancellor Angela Merkel said Thursday.
Mar 25, 2021
0
2
The head of German pharmaceutical company BioNTech said Monday that there is no need to waive patents on coronavirus vaccines because manufacturers will be able to produce enough shots to supply the world over the coming ...
May 10, 2021
0
2
Activists cheered, Big Pharma complained and government leaders assessed next steps on Thursday after the Biden administration's blockbuster move to support an easing of patent and other protections on COVID-19 vaccines that ...
May 6, 2021
0
2
Getting a COVID-19 vaccine to the right people could change the course of the pandemic in the United States. But who are the right people?
Dec 3, 2020
0
3
The European Union and drugmaker AstraZeneca sparred Wednesday over a delay in coronavirus vaccine deliveries as the deepening dispute raises concerns about the increasing competition for limited supplies of shots needed ...
Jan 27, 2021
0
5
